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Summary 
Immunoglobulin (Ig) genes were isolated from unamplified conventional as well as polymerase 
chain reaction-generated cDNA libraries constructed from the peripheral blood cells of a patient 
with complete DiGeorge syndrome. Comparison of the sequences of 36 heavy chain clones to 
the recently expanded database of human V. genes permitted identification of the germline V. 
genes that are expressed in this patient as well as placement of 19 of these genes in a partially 
resolved 0.8-mb region of the human V. locus. The pattern of V. gene use does not resemble 
the fetal (early) repertoire. However, as in the fetal repertoire,  there are a number of cDNAs 
derived from germline genes that previously have been identified as autoantibodies. Two D/~ 
sequences also were identified, as was another sequence resulting from a unique recombination 
event linking J. to an unidentified sequence containing a recombination signal sequence-like 
heptamer. All of the DiGeorge cDNAs are closely related to germline V~ genes, showing little 
or no evidence of somatic mutation. In contrast, comparably selected IgM V. sequences derived 
from normal adult and age-matched human libraries,  and from a second DiGeorge syndrome 
patient in whom the degree of thymic dysfunction is much less severe, exhibit considerable evidence 
of somatic mutation. The absence of somatic mutation is consistent with the atypical development 
of functional antibody responses associated with complete DiGeorge syndrome and implicates 
a role for T  cells in the generation of diversity within the B cell repertoire. 
nalyses of the Ig repertoire, as represented in peripheral 
blood,  have been  the focus  of recent investigations. 
Owing to the relative ease of PCR amplification, most of 
the efforts have been directed at the CDR3 junction and the 
generation of diversity through D. element (as well as J.) 
usage and modification (1-3). Studies of the human fetal and 
cord blood repertoires have been carried out using conven- 
tional cDNA libraries  (4-7), and while the normal human 
V. repertoire has not been studied extensively  in terms of 
expression  of  specific  V.  genes,  recent  advances  in  the 
enumeration and mapping of germline V. genes (8-10) now 
allow such investigations. These findings have had consider- 
able impact in terms of our understanding of the develop- 
mental expression of Ig genes as well as the relationship of 
autoimmunity to specific genes. The nature of Ig gene usage 
in  human  primary  immunodeficiency diseases, including 
X-linked agammaglobulinemia  (11-13) common variable im- 
munodeficiency  (14) and severe combined immunodeficiency 
(15), has been examined. The present report addresses the 
Ig gene repertoire of patients with DiGeorge syndrome, a 
developmental field defect that involves dysmorphogenesis of 
the third and fourth pharyngeal pouches and is associated 
with varying degrees  of fascial dysmorphia, hypoparathy- 
roidism, anomalies of the great cardiac vessels, and partial 
development of the thymus. Abnormal B cell function in these 
patients is associated with the thymic abnormality and results 
in susceptibility to microbial pathogens, despite the main- 
tenance of low to near normal levels of circulating Ig. The 
nature of the Ig genes that are transcribed in these patients 
is significant  in terms of their impaired antibody function. 
In this regard, we have produced cDNA libraries from the 
PBMC of a DiGeorge patient with near complete failure of 
development of the thymus as well as the T  cell compart- 
ment of immunity. Gene transcripts in this patient are com- 
pared with those expressed by normal neonates, a normal adult, 
and a second patient with a much less complete form of the 
disease, so-called partial DiGeorge syndrome. 
Materials and Methods 
Patients.  At the time of study, the patient was an 8-too-old fe- 
male born full term after an uneventful pregnancy to unrelated 
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with hypocalcemia and hypophosphatemia in the neonatal period 
and had undetectable levels of parathyroid hormone (PTH  =  <1 
pmol/liter). Since the age of 3 too, the patient suffered from recur- 
rent respiratory tract infections, pneumonia, persistent oral can- 
didiasis,  and failure  to thrive. A vascular ring (right aortic arch 
and aberrant left subclavian artery) was evident on cardiac work- 
up. At 2 mo, the patient received oral polio vaccine and diptheria, 
pertussis, tetanus vaccine and at 6 too, the child developed diarrhea, 
and polio virus was isolated from the stool. At 8.5 mo, immuno- 
logical parameters were: T3, <1% (normal range [N] =  63-85%); 
T4, <1% (N  =  37-57%); T8, 2% (N  =  18-36%); Tll,  10% 
(N =  71-89%); NK, 8% (N =  2-14%); B1, 86% (N =  7-19%); 
B4,  86%  (N  =  8%); B6,  10%  (N  =  2%); TCR ~//8,  <1% 
(N =  4-10%); TCR,v/fl, <1% (N  =  64-68%); and CD5, 54% 
(N  =  80%). The T  cell numbers and proportions were exceed- 
ingly low and the B cell numbers and proportions were markedly 
elevated. Since the patient had very few CD3 § T ceUs, the CD5 + 
cells were likely to be B cells. Thus, ",~70% of the patient's B cells 
were CD5 + and this percentage is similar  to that of normal in- 
fants of a comparable age (16). The total lymphocyte count was 
2,128/mm  3 (10 wk earlier, 4,088/mm3). Thymulin level was not 
detectable, at <1:4 dilution (N =  1:16-128), mitogen-induced lym- 
phocyte transformations and mitogen-induced production of Ig- 
secreting cells  were  decreased.  At  3  mo,  IgG  =  187  mg/dl, 
IgA =  <6 mg/dl, IgM --- 30 mg/dl, and anti-B isohemagglutinin 
titer  =  1:2. 
The Ig V. gene repertoire was also studied in a 31-too-old male 
child with partial DiGeorge syndrome who had normal facial fea- 
tures, history of hypoparathyroidism, hypocalcemia in the neonatal 
period, cardiac abnormalities, and reduced T cell numbers, to ap- 
proximately one-half of the normal values for age-matched con- 
trols. The normals used for comparison were a healthy adult volun- 
teer and a 9-too-old child. 
PBMC were prepared from 20 ml of the patient's blood by the 
standard  Ficoll-Hypaque method.  RNA  was  prepared  by  the 
R.NAzol B method (Cinna/Biotecx, Houston, TX). For conven- 
tional cDNA library synthesis,  poly(A) + RNA was  selected by 
oligo(dT)-conjugated magnetic beads (Dynal, Oslo, Norway). A 
cDNA kit (Pharmacia  Fine Chemicals,  Piscataway, NJ) was used 
with only minor modification to synthesize cDNA that was ligated 
into ~  gt11. 
A rapid amplification of cDNA ends [RACE] library was gener- 
ated from 5/xg of whole RNA by reverse transcription  with 200 ng 
ofoligo(dT) primer and 30 U AMV reverse transcriptase (Seikagaku, 
Rockville, MD). The first-strand product was faltered  in an Ultrafree 
MC 10,000-molecular weight cutoff (Millipore Corp., Bedford, 
MA) to remove excess primer. The cDNA was tailed with oligo(dG) 
for 30 rain using 30 U ofTdT (GIBCO BILL, Gaithersburg, MD), 
filtered, and PCR amplification (17) was performed using an EcoRI- 
linked poly(dC) (n  =  14) and an internal IgM constant region 
primer: TTGCACACCACGTGTCG (codon 203-209). The PCR 
product was digested with EcoRI (using the natural site in the 
first exon of the IgM heavy chain C region [C,1) and applied to 
a 1% NuSieve GTG agarose gel (FMC, Rockland, ME). The gel 
section containing material >300 bp was  heated to liquify the 
agarose, extracted with phenol, ethanol precipitated, and ligated 
into )x gt11. 
Library screening was done with an oligonucleotide probe com- 
plementary to J, 1-6: 5'-TGAGGAGACGGTGACCAGGGTTCC- 
TTGGCCCCAG-Y. Positive clones were amplified with an EcoRI- 
linked J, primer together with either a right or left )x arm primer 
and the product was subcloned into M13 for sequencing.  Several 
cDNAs were selected from the RACE library by screening with 
DNA probes produced by PCK using family-specific framework 
region I (FR1) ~ and FR3 primers (18). To determine the C. iso- 
1 Abbreviation used in this paper: FtL, framework region. 
Table  1.  DiGeorge cDNAs Are Grouped by Their Library Source, Conventional Library vs. RACE Library 
Clone  V. family  Length (codon)  Germline parent  Substitutions 
22  1  CDR1  (34) 
27  1  5' leader 
37  1  FR3  (75) 
3  3  5' leader 
4  3  CDR.2  (60) 
13  3  5' leader 
15  3  5' leader 
17  3  5' leader 
21  3  5' leader 
31  3  5' leader 
34  3  5' leader 
36  3  5' FR2 (36) 
38  3  5' leader 
10  4  FR2 (41) 
20  4  3' leader 
28  4  3' leader 
Conventional library 
71-5 (148P) 
1-18 
DP10*  or HV1263(?) 
DP77 (3-21) 
DP42  (3-53)* 
3-7 
GLSJ2* 
3-9 
9-111  (3-30)* 
DP51  (3-48) 
DP58 
9-1  (3-15)* 
DP50 
4-4 
DP65  (4-31) 
4.11  (4-59)* 
conanued 
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reaction was carried out using C.-specific primers. 
Homology searches  to V. sequences  containing open reading 
frames,  extracted  from  GenBank  (8-10),  used  I/FIND  (Intel- 
ligenetics, Mountain  View,  CA). 
Results 
V~ Family Representation in the Patient with Complete Di- 
George Syndrome.  Owing to the potential of PCR-RACE 
methods  (19)  for  biasing  the  representative  frequency  of 
different V. genes and gene subsets  (see below),  a conven- 
tional cDNA library was prepared from 70 #g of patient whole 
tLNA in parallel with the equivalent amount of RNA from 
a normal adult control.  2  x  105 recombinants were gener- 
ated in the DiGeorge library and  16 Ig J. + clones were re- 
covered.  Parallel  screenings  of the  (normal)  control library 
yielded ,x,l,000 J.+  cDNAs and •106  recombinant plaques. 
All of the cDNAs recovered from the DiGeorge syndrome 
patient conventional library were sequenced. 11 sequences ex- 
tend  from the  leader  to J.  and  5  are truncated  within  V. 
(Table  1);  all represent  a correct  open reading  frame.  Each 
of the  16  cDNAs  recovered from  the  conventional  library 
is derived  from a  different  germline  gene (see below). 
The J.-selected  clones  (nos.  203  and  205-211)  from  the 
PCR-RACE  library are all V.I,  suggesting  a  possible VHI 
amplification bias (see below). Therefore, an additional nine 
clones were selected from this library using V. family-sped- 
Table  1.  (continued) 
Clone  VH family  Length  (codon)  Germline parent  Substitutions 
RACE library 
203  1  5'leader  1-18 
205  1  5'leader  1-18 
206  1  5'leader  1-18 
207  1  5' leader  1-18 
208  1  5' leader  DP10* 
209  1  5' leader  1-18 
210  1  5' leader  DP10* 
211  1  5' leader  DP10* 
V.-selected race 
1.1  1  Mid  leader  1-3B 
1.2  1  5' leader  1-18 
1.4  1  5' leader  1-18 
1.5  1  5' leader  1-18 
3.1  3  5' leader  GLSJ2* 
4.1  4  5' leader  DP65  (4-31) 
4.3  4  5' leader  4.21  (4-34) 
4.5  4  5' leader  4.21  (4-34) 
4.2  4  5' leader  V2-1  (4-39) 
FR3(R)  89GTG"~GGG 
FK3(2K) 75ACG--~GCG 
84  TCT--~CCT 
FR1  (S),  CDR2  (R) 
18GTG-~GTA 
51ATC-~ACC 
The clones from the RACE library are either isolated by a V.-independent  screening method (J.) or by V. selection. The germline parent gene 
is determined by homology to the database and, in most cases, is indicated by the original name. Germline DPS0 was first reported as 301%9 (35) 
and 1-18 was reported as DP14; the alternative designations are used for simplicity. All cDNAs are 100% identical to the first germline gene indicated 
except where there is a substitution noted (last column). Substitutions refer to the functional region. Silent (S), replacement (R), and the number 
of mutations,  if more than one, are indicated, followed by codon number (36) and the Slx*cifir  nudeotide  substitution relative to gene 1-18(DP14). 
The mapped gene equivalent (9) is underlined and, in some cases, placed in parenthesis when the original name is different or when the germline 
gene from the map differs slightly from the first germline gene listed. For example, DP51 (cDNA31) is identified as mapped gene 3-48, DP77 (cDNA 
3) as 3-21, DP42 (probable cDNA 4) as 3-53, DP65 (cDNAs 20 and 4.1) as 4-31, and 4.11 (cDNA 28) as 4-59, even though the germline sequences 
homologous to the cDNAs differ by a single nucleotide from the indicated germline sequence derived from the map. Clone length indicates where, 
in a functional region of V., the sequence begins with the codon number in parentheses (36). 5' leader means the sequence obtained begins up- 
stream of or near the 5' end of the V. leader sequence. All germline genes denoted DP are taken from (10). Gene 71-5 (23) was originally consi- 
dered a pseudogene and later determined to be a functional gene (10). Other germline genes are HV1263, GLSJ2, 9-III and 9-1,4.11,4.21, and V2-1 (8). 
* Genes that are associated with the fetal repertoire. 
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lies. Overall the RACE-generated clones are longer than those 
produced by conventional cDNA synthesis, with all but one 
having a complete leader sequence. While there are differ- 
ences between the two groups of sequences, there are some 
germline elements common to both libraries, specifically  V.I 
1-18, V.III GLSJ2, and V.IV DP10. Detailed inspection of 
the noncoding regions and the 5' terminus of the most com- 
monly amplified RACE clones in this study indicates that 
the V.I genes DP10 and 1-18 are not homologous (data not 
shown). Thus, the basis for a TdT preference is not evident 
from comparisons of these sequences. These observations em- 
phasize the difficulty in using PCR libraries to quantitate 
the relative frequency of different transcript  classes (i.e., V. 
families or subfamilies) or even to determine their presence 
or absence (R.  N. Haire and G. W.  Litman, unpublished 
observations). However, in some cases, for example the par- 
tial DiGeorge syndrome patient described in Table 2,  V. 
family representation in the PCR-RACE cDNA library ap- 
pears to be proportional to germline representation  and is 
similar to the results from the conventional library  of the 
DiGeorge syndrome patient and from the normal controls 
(data not shown). Notwithstanding,  these complications, 
PCR-amplified clones can yield very useful information re- 
garding junctional diversity and somatic mutation. 
Specific  V,, Gene Use.  30 cDNAs, including no. 28, the 
single IgA clone (all others are IgM), exactly match germ- 
line database sequences (Table 1). Two clones with incom- 
plete CDR2 sequence can be identified from the available se- 
quence, and the unique matching germline parent is indicated. 
Clone 37, truncated in FK3, is homologous to two known 
germline genes. Only clone 209, with a replacement substi- 
tution in CDK2 and a silent mutation in FK1, is consistent 
with a somatically modified sequence but could also reflect 
a polymorphism and/or represent the product of  closely  related 
genes, PCR-introduced cloning errors, or sequence determi- 
nation errors. The substituted  nucleotides in clones 205 and 
209 were confirmed  by recloning and resequencing. The pre- 
dominance of mismatches in FRs in not usually considered 
characteristic of somatic mutation, and the mutations are at 
different positions, suggesting that the FR3 substitutions  in 
clones 205 and 206 are not due to a polymorphic variant of 
1-18. Finally, it is noteworthy that the incidence  of mismatched 
nudeotides, while low, is higher in the RACE library than 
in the conventional  library. Taq polymerase  error arising during 
the preliminary RACE amplification cycles  may be an expla- 
nation for these substitutions. 
Eight V.III cDNAs from the conventional library extend 
from the 5' leader through J. and are matches with germ- 
line sequences: DP77, DP50, DP51, DP58 (10), 3-7, 3-9 (9), 
GLSJ2 (8), and 9-Ili (20). Clone 13 has a 9-bp V. trunca- 
tion relative to germline 3-7 at the V.-DH junction. Clone 
36 extends from FR2  and corresponds  to germline V.III 
9-1 (20). Truncated clone 4 exactly matches and probably is 
derived from germline gene DP42  (10). Transcripts using 
V.IV germline genes 4-4 (9), DP65 (10), and 4.11 (21) also 
were recovered in screening the conventional library. Clone 
10 represents the first cDNA described that derives from the 
newly defined  germline gene 4-4.  Four  additional  V.IV 
cDNAs derived from the RACE library correspond to germ- 
line genes DP65,  4.21 (21), and V2-1 (22). 
V.I cDNAs identified in the conventional library are de- 
rived from at least three germline genes. 71-5 originally was 
considered a pseudogene (23) on the basis of an atypical in- 
tron splice sequence as well as an atypical RSS nonamer, but 
clone 22, while truncated, is homologous with 71-5 through- 
out its observed length and appears to be a functional tran- 
script. On the basis of FR3 identity, cDNA clone 37 is as- 
signed tentatively to germline gene DP10 or HV1263 (10). 
In the RACE library, V.I cDNAs are derived from germ- 
line genes 1-3b (24) and DP10.  The remaining V.I genes 
correspond as perfect matches or with limited FR3 substitu- 
Table  2.  A  Comparison of Gene Usage in Partial and Full DiGeorge Syndrome 
DiGeorge (n  =  33)  Partial DiGeorge (n  =  25) 
Germline parents identified 
Nonmatching sequences 
Substitutions/V. 
Sequences greater than two substitutions 
Expressed germline genes shared 
with DiGeorge patient 
Expressed germline genes shared 
with fetal repertoire 
CDR3 length (bp) 
19  11(- 14) 
3  7(- 11) 
0-2  0-31 
0  7 
Not  applicable  7 
6  2 
23( + 10)  25( _+ 8) 
Germline parents identified indicates the minimum  and probable maximum number of different genes expressed in the cDNA repertoires. The smaller 
number reflects only the positively identified germline genes while the larger number represents additional substituted sequences that are similar to 
and probably derived from other known germline VHs. The overall range of substitutions per V~ gene is given in the third line of the table, n, 
number of clones studied.  CDR3 length is defined as the total number of nudeotides found between identifiable V.- and J,-encoded  sequences. 
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which has single changes in FR1 and CDR2, and therefore 
may represent a somatically mutated gene (1-18), as discussed 
above. 
With the recently expanded data bases of human V. se- 
quences (9,  10), the incidence of somatic mutation in the 
IgM cDNAs of normal individuals can be estimated. Our 
analysis of the cDNAs from the human cord blood library 
(6) reveals that 7 of 11 sequences do not match database se- 
quences and only 4 are exact matches. The nonmatching se- 
quences differ by an average of 10 bp each with 50% of those 
in CDR2, indicating either somatic mutation or expression 
of other unknown germline genes.  In the normal adult li- 
brary,  which we constructed in the course of this study, 
"~,45% of the 23 fully analyzed sequences correspond to germ- 
line V. gene transcripts, similar to the ratio observed for 
cord blood. In a second control library, derived from the pe- 
ripheral blood of a 9-mo-old nonimmunodeficient infant, 7 
of 11 sequences do not match database germline genes with 
at least five substitutions per cDNA. 
Matching cDNAs to germline sequences is more difficult 
in  the  RACE  cDNA  library  prepared  from  the  partial 
DiGeorge syndrome patient, summarized in Table 2, due to 
the presence of some sequences that are either highly muta- 
ted or derived from unidentified germline genes. The unidenti- 
fiable sequences comprise a minimum of seven cDNAs: two 
V.I and five V.III, with an average of 16 (_+ 10) "randomly" 
distributed substitutions compared with the nearest germ- 
line V.; i.e., similar cDNAs are substituted at different sites. 
These appear to be highly somatically mutated transcripts. 
Unlike the situation in the DiGeorge syndrome patient, the 
partial DiGeorge syndrome patient cDNAs are IgM, as well 
as IgA and IgG, but there are both unmutated and highly 
mutated cDNAs of each isotype. 
The availability of a partial physical map of the human V. 
locus (9) permits mapping of the corresponding germline genes 
expressed in the complete DiGeorge syndrome patient (shown 
in Fig.  1) along with the relative  map positions of genes 
identified in fetal libraries  (4,  5,  7). Both groups of genes 
are widely dispersed over the locus and are largely nonover- 
lapping, with the exception of mapped genes 4-59/58P2, 
3-53/63Pl, 3-30/1-9 III, and 3o15/20P1. However, two un- 
mapped genes also are shared between the fetal libraries and 
the DiGeorge syndrome  patient, GLSJ2(56P1) and DP10/51P1. 
Therefore, only 32% of the genes from the DiGeorge syn- 
drome patient are also associated with a "fetal" repertoire, 
i.e., approximately two-thirds of the expressed genes are not 
fetal.  The partial DiGeorge syndrome patient shares seven 
germline genes (65%) with the repertoire from the patient 
with complete DiGeorge syndrome, but only shares two 
(18%) with the fetal repertoire (data  not shown). The se- 
quences obtained from the human cord blood cells are not 
homologous to any of those from the DiGeorge syndrome 
patient; however, this comparison is complicated by a high 
frequency of apparent somatic mutation present in the cord 
blood sequences. 
Germline genes that are associated with autoantibodies also 
are shown (Fig. 1). Clone 1.1 is derived from germline 1-3b. 
This gene differs by only a single nucleotide from an anti- 
DNA autoantibody (24). Note that the germline gene 1-3b 
was identified as haplotype B in that investigation, while done 
10 from our patient with partial DiGeorge syndrome is de- 
rived from gene 4-4, haplotype A. Other specific genes ex- 
pressed in this patient with the partial DiGeorge syndrome 
that may be associated with autoantibody include: germline 
4.21 (mapped as 4-34), a polyreactive rheumatoid factor, and 
germline 9-1 (3-15), an anti-DNA antibody (8).  Germline 
1-18 differs from a reported autoantibody ValGRR  by a 
single nucleotide and germline 1.9III (3-30), which also differs 
by a single nucleotide from the autoantibody Kim 4.6. Fi- 
nally, germline gene 4.11 is mapped as gene 4-59 and is related 
to autoantibody Pag-1 (9), although four nucleotide substi- 
tutions have occurred. Of the seven germline genes expressed 
in the complete DiGeorge syndrome patient that are homol- 
ogous to reported autoantibody sequences, all but one, GLSJ2, 
are located within the mapped region. Detection of specific 
,~.  A,B  ~0  J H  OH 
Fetal  i  n  l  i  l  l  l  l  I  I  ￿9  ￿9  ￿9  ￿9  ￿9  ￿9  ￿9 
4-50  5-51  3-30  3-23  3-15 3-11  2-5  1-2  5-1 
3 -53 
*-~  AAB  A~  A~  AA.  AA.  J H  OH 
PO1  am  li  a  m  i  iin  n  n  m  !  m  am 
el  ￿9  ￿9  ￿9  ￿9  li  ￿9  ￿9  ￿9  ￿9  ￿9  el 
4-59  5-53  3-48  4-39  4-34  3-30  3-21  1-16  3-15  3-9  3-7  4-4 
1-58  4-31  I-3b 
Figure  1.  The relative physical position of the mapped germline parents for cDNAs derived from the complete DiGeorge syndrome patient compared 
with those assigned to the "fetal repertoire" (4, 5, 7). Fetal genes are mapped if they occur at least twice in the references cited, with the exception 
of 2-5, which was encountered only once. Note that not all germline parents identified in the DiGeorge  and fetal repertoires could be assigned to 
the physical map and that the sequences shown are limited to those identified and mapped in a 0.8-rob J,-C. proximal region (9). Numerous other 
V. genes have not been mapped as of yet (10) and must lie further upstream from J., lie outside of the contiguous portion of the V. locus, or represent 
polymorphisms.  The relationships between alternative names for the germline gene and designation  of the mapped gene are evident in Table 1. The 
notation AAB indicates a gene coding for a cDNA identified as an autoantibody (9). In most cases, the sequences of the autoantibodies are identical 
to or differ by a single nucleotide from the mapped germline genes, except in the case of 4-59, which differs by 4 bp. The relative position  shown 
is approximately proportional to the distance between genes on the 0.8-rob map. 
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libraries is more dif~cult because  of the large  number of 
somatically modified sequences; however, to date only autoanti- 
body-related  genes 4.21, 1.9111, hv3005, and 1-18 have been 
observed. 
CDR3 Region.  Sequences of all cDNAs derived from the 
complete DiGeorge syndrome patients,  from the conserved 
Cys (codon 92 FlL3) at the 3' terminus of V. through the 
conserved  Trp (codon 103 FlL4) of J, are shown in Fig. 2. 
A high proportion of the cDNAs have a recognizable (germ- 
line) D. element that  has been joined in the conventional 
V-D-J manner;  seven different D. families  are represented 
(2). The most common D. family is DLlL (33% of the se- 
quences), followed by DXP (23%), DN (20%), D.fl (10%), 
DK (7%), and DM (3%). We did not identify any DA or 
D.Q52  members,  and only  one  probable  DIlL  sequence 
(done no.  206)  is  noted.  While the DLlL family may be 
proportionally increased, the relative occurrence of most other 
D families is in good agreement with those reported by others 
investigating Ig expression in the peripheral blood of normal 
individuals (1,  2).  The most  commonly used specific  D. 
genes are D4 (n  --  5), DN1-TG (.  =  3; see below), DN1 
(or DN4 in some cDNAs; n  =  3), and DXP4-D23/7  (n  = 
4). We did not observe inverted D. sequences of significant 
length that were not accountable for by other, noninverted 
D's. One case of joining of two D. elements was observed 
in clone 3.1, in which D2 and D21/9 are joined in a particu- 
larly long CDlL3. 
3" V,  ~R3  5" J, 
GLDNI  GGGTAT~TGGTAC 
27  TGTGCGAGAGA  GAATC  ..........  A  ....  ACTACTACTACGGTATGGACGTCTGG  J6(-7) 
04  TGTGCGAGAGA  tGG  ..................... GAG  CTTTGACTACTGG  J4(-4) 
28  TGTGCGAGAG~  GCCCA  ......  C  ACTTTGACTACTGG  J4(-3) 
DIR  GCCCCCACCCAG 
206  TGTGCGAGAG  .....  ￿9  ......  CGTGAAG  ACTACTACTACTACGGTATGGACGTCTGG  J6(-3) 
PUT DNI(TG}  TATAGC~%GTGGCTGGT 
03  TGTGCGAGAGA  ............  A-CCCTTGG  CTACTGG  J4(-10) 
10  TGTGCGAGAGA  tAGCCCCTTGGG ..............  ATGCTTTTGATATCTGG  J3(-0) 
36  TGTACCACAGA  tTCTCCGGT  ............  C-  TTGACTACTGG  J4(-6) 
GLD4  AGGATATTGTAGTAGTACCAGCTGCTATGCC 
210  TGTGCGAGAGA  ---C  .....................  AGGGA  TTTGACTACTGG  J4(-5) 
1.2  TGTGCGAGAGA  GATCCTGACCCCT ..................... C  ATGCTTTTGATATCTGG  J3(-0) 
4.1  TGTGCGAGAGA  tc  .........................  GG  CTACTGG  J4? 
4.2  TGTGCGAGAGG  GGGGCGC  ..........................  ATCAG  TTGACTACTGG  J4(-6) 
209  TGTC-CGGAG  AATGTGCG  .......  TC  CTACGGTATGGACGTCTGG  J6(-13) 
GLD5  GTATTACGATATTTTGACTGGTTATTATAAC 
17  TGTGCAAAAG_AA  .....................  N  GCTTTTGATATCTGG  J2(-27) 
GLD3  AGCATATTGTGGTGGTGATTGCTATTCC 
37  TGTGCGAGAG  tc  ................ C  .....  CCG  ACTGGTACTTCGATCTCTGG  J2(-2) 
PUT D2(AG)  TAGTGGGAGCTACT 
207  TGTGCGAGA  AGCTCAC  ............ ACGA  CTTTGACTACTGG  J3(-3) 
GLD2  AGGATATTGTAGTGGTGGTACg2TGCTACTCC 
38  TGTGCGAGA  ACG  ......................  CTACTTTGACTACTGG  J4(-l) 
GL21/9  GTATTACTATGATAGTAGTGGTTATTACTAC 
4.3  TGTGCGAGAGA  GGTGN  ................. GCCCAAC  ACTGG  J4(-12) 
3.1  TGTGCGAGAGA  --G  .....................  C-CT-AC  ......................  CAT  CTTTGACTACTGG  J3(-3) 
GLDHFLI6  TGACTACC,  GTGGTAATCCCACCGGTT 
i.i  TGTGCGAGAGA  GGGCCAA  .....  GGAAA  TTGACTACTGG  J4(-6) 
1.5  TGTGCGA  CT  ........  GGC  CTACGGTATGGACGTCTGG  J6{-4) 
20  TGTGCGAGAGA  CC  ............  TGGGGGGGGGAT  TTTGACTACTGG  J4(-5) 
GLDXP4  GTATT,,~X~GATTTTTGGAGTGGTTATTATACC 
21  TGTGCGAAAGA  tcGAGG  .........................  GGGG  CTACTGG  J4(-10) 
4.5  TGTGCGAGAG~  --C  ............  CG  GACTACTGG  J4(-8) 
34  TGTGCGAGAGA  CACC  .......  GTT  NCTACTTTGACTACTGG  J4(-0) 
205  TGTGCGAGAGA  CGGACC  ....  AC  ................ CCGGAAA  ACGGTATGGACGTCTGG  J6(-15) 
GLDKI  GTGGATATAGTGGCTACGATTAC 
203  TGTGCGAGAGA  tcAGGTAGAG  ........  A  ....  TG  GACTACTGG  J4(-8) 
GLDK4  GTGGATACAGCTATGGTTAC 
211  TGTGCGAGA  GNTTATAC  .................. GGC  CTGGTTCGACCCCTGG  J5(-4) 
GL21/10  GTATTATGATTACGTT~TTATGCTTATACC 
208  TGTGCGA  CCC---G  ............... CGCTCTTG  ATGCTTTTGATATCTGG  J3(-0) 
GLDMI  GGTATAACTGGAACTAC 
13  TG  CAC---GC  ........  ACTACTTTGACTACTGG  J4(-0) 
GLDXP"  GTATTACTATGGTTCGGGGAGTTATTATAAC 
15  TGTGCGAGAG  CTTGGGAA  ................. GGGGATC  CGACCCCTGG  JS(-10) 
UNKNOWN Ds 
22  TGTGCGGCAGA  tcGACTGCTCGGC  GCTTTTGATATCTGG  J3(-2) 
1.4  TGTGCGAGA  TCCCCGCT  CTTTGACTACTGG  J4(-4) 
31  TGTGCGAGAG  GAGAGCGCCGGNGG  TACGGTATGGACGTCTGG  J6(-14) 
Figure  2.  CDR3 sequences are shown under the corresponding  complete germline D  core sequences (bold). At the left are nudeotides attributable 
to the 3' end of V,.  determined  from homology with germline genes  indicated  in Table 1, to codon 95.  At the right are nudeotides attributable 
to 5' J, indicated to the conserved TGG (codon 102). Nucleotides underlined  at the end of V. and the beginning of J, are common to both the germ- 
line V  or J and the germline D. segment involved.  Dashes  indicate nudeotide identity with the germline D. and substitutions  are indicated within 
the dashed regions  (except for the V-D1-D2-J clone 3.1, which has probable N  region  bases between the D's). The nucleotides  to the right and left 
of dashed regions  are assumed  to be N  region additions  unless  they can be identified  as P nucleotides  (lower case). Note that P nudeotide identity 
can be extended  to the first TC pair within the CDR3 of clone 210 and similarly to the first T in clone 17 CDR3. Dots indicate a space introduced 
to maximize homology. Putative  germline genes  DN1-TG (1) and D2-AG are shown as consensus  sequences  derived from eight and seven cDNAs, 
respectively,  obtained  from other  patients  and normal  individuals  (data not shown). 
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Yamada et al.  (1) and encountered in three of the cDNAs 
from this patient also is found in the control and probably 
represents an undescribed germline element. Similarly a D2 
variant, D2-AG, was encountered in the DiGeorge syndrome 
patient and controls (K. N. Haire and Y. Ohta, unpublished 
observations).  The core sequences for the putative D. ele- 
ments are shown in Fig.  2. 
In general the CDR3 sequences in the patient with com- 
plete DiGeorge syndrome have rather high homology vs. 
normals to the germline core sequences. Somatic mutation 
rates within D, elements are difficult to estimate due to N 
region additions, but are present at ,03% in the sequences 
from the DiGeorge syndrome patient vs.  '~6-7%  in con- 
trols (Fig.  2; 1, 3). D. reading frame use in this study ap- 
pears to be unrestricted in the normal sequences, in contrast 
to murine Ig genes.  For example,  DN1  is used differently 
in all three reading frames in clones 27, 04, and 28.  Simi- 
larly,  clones 210, 1.2, and 4.2 use D4 in different reading 
frames. 
Overall CDR3 length, defined here as the sum of D, P, 
and N region (7) contributions, appears to be reduced some- 
what in the patients with partial or complete DiGeorge syn- 
drome compared with that of normal individual adults, with 
a mean of 23 (+10) bp in the DiGeorge syndrome patient, 
and 25 (_ 8) in the partial DiGeorge syndrome patient vs. 
",,33 in the normal adults (2). This latter finding was also 
confirmed by observations with normal sequences examined 
in the course of the present study (data not shown). How- 
ever, mean CDR3 lengths of 24 and 14 have been observed 
in neonates (2) and in B cells from fetuses (7), respectively, 
and the CDR3 length seen in the patients' sequences may 
be  normal for individuals at  that  age.  The patient  with 
DiGeorge syndrome exhibits N region nucleotide additions 
of 8.1 (_+ 4) similar to the size distribution observed by Sanz 
(2); approximately one-third of the sequences in this study 
have an addition of >10 bp. With the possible exception of 
clone 17, none of the CDR3 regions that have identifiable 
D. segments appear to lack N region additions.  About one- 
third of the sequences from the DiGeorge syndrome patient 
have 5' P nucleotides at the V-D junction, compared with 
,o50% in cDNAs derived from normal adults (1) and ,078% 
in those derived from fetal cDNAs (7); 5' exonuclease ac- 
tivity is evident, especially at the D-J junction, in many of 
the sequences. J  element usage in this complete DiGeorge 
syndrome patient is: J4 (*50%), J3  (18%), J6 (18%), J2 
(6%), J5 (6%), and J1 (not seen). These frequencies correspond 
well with those from our normal databases and from avail- 
able sequence data (1, 2). 
Atypical Transcripts.  In the course of screening the RACE 
cDNA library from the patient with complete DiGeorge syn- 
drome using the J. probe, we isolated and sequenced three 
short J, + transcripts that lack V, regions. Two transcripts 
are typical of the D# type (25): DiG3 consists of D4joined 
to J.6, with evidence of exonuclease activity at the D/J junc- 
tion,  and DiG4  consists  of D4 joined to J.4.  Both tran- 
scripts begin at the 5' noncoding (D intron), '~135 bp from 
D4, but differ in the degree of exonuclease catalyzed elimi- 
nation of D4 sequence. In both cases, C# (IgM) sequences 
are contiguous with J.. 
A third transcript obtained from the patient with com- 
plete DiGeorge syndrome (DiG 5) is unique. J.6,  with 19 
bp eliminated 5" is joined to 209 bp of a sequence that is 
undetectable in searches of the mammalian database. How- 
ever, 37 bp upstream from the J.6 sequence is a perfect RSS 
heptamer, CACTGTG. This sequence also contains IgMjoined 
to J. and, as with the D/~-like sequences, does not represent 
a spurious PCR priming event. The sequences of these three 
atypical transcripts from the DiGeorge syndrome patient are 
shown in Fig. 3. Finally, we have identified a single D# se- 
DIG3  D4/J6 D~ 
aaaagccccctggaaat  cat  agt  at  cagcaggagaact  agccagagacagcaagaggggact  cagt  g 
RSS  RSS  D 
a  c  t  c  c  c  gc  ggg  ga  c  aggaGGATTTTGTgggggct  cgt  gt  CACTGTGAGGATATNGTAGTAGTACCAG 
J 
CTGCTATct  t  gCTACTACTACTACGGTATGGACGTJ6  -  C~ 
DIG4  D4/J4 (?)  D~ 
aaaaaccccct  ggaaatmat  aggt  at  aagcagggagaact  agcaagagacagcaagaggggact  cag 
RSS  RSS  D 
t  a  accc  c  cgt  ggggacaggaGGATTTTGGgggggct cgt  gt  CACTGTGAGGATATTGTAGTAGTACC 
AGCTGCTATGgggtaJ4  -  C~ 
DIG5 
gactacaatctaagtctttctgatttcaaagctcctgcttattaccacttcacagcacacctagaaa 
gcat  aaggtgggagcaggttaaaatgcatacttgtctttggtt  at  cccctctacttt  cctgtccttc 
BSS 
tct  gcct  acct  gt  at  ctgcat  cct  t ggtCACTG~kU, gaaaatt  at  ctt  ct  agggt  cct  gtggwgacag 
J 
agggcTATGGACGTJ6  -  C~ 
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Figure 3.  D/~ transcripts (DIG3 
and DIG4) and one aberrant tran- 
script (DIGS) are shown from the 
beginning  of recognizable germline 
D. sequence up to the J. oligonu- 
cleotide  sequence  used  for  sub- 
cloning, m =  c or a, and w =  t or 
a.  The  presence  of  C#  was 
confirmed by PCR with isotype- 
specific  oligonucleotide  primers. 
Recombination signal sequence  hep- 
tamer  and  nonamer  (RSS)  are 
shown in bold, J. sequence 0D is in 
italics,  followed  by  the J  family 
designates, with the remaining J se- 
quence,  that of the PCR primer, 
omitted. D. (D) coding sequence is 
underlined. quence each from the peripheral blood of the partial DiGeorge 
syndrome patient and from a normal adult control (also from 
a RACE library) but have detected no counterpart to the aber- 
rant transcript, DiG 5, from the patient with the complete 
DiGeorge syndrome. 
Discussion 
Considerable variation in the degree of immunodeficiency 
is noted in patients with DiGeorge syndrome. The T  cell 
immunodeficiency ranges  from mild deficiency  in  T  cell 
number and function to virtually complete absence ofT lym- 
phocytes, absence of thymulin, and very high numbers and 
proportions of B lymphocytes in the blood. Patients with 
DiGeorge syndrome have a propensity to develop a high fre- 
quency of autoimmune manifestations and autoimmune dis- 
ease. The profound T cell deficit present in the patient with 
severe or complete DiGeorge syndrome studied here occurs 
in <10%  of patients afflicted with this primary immuno- 
deficiency disease. A near complete lack of T cells provoked 
speculation that the B cell population might be comprised 
of a limited number of clonal lines with attendant restriction 
in the Ig V. and possibly D. as well as J. repertoires due 
to presumed abnormalities of T cell-dependent B cell devel- 
opment. However,  the repertoire of Ig that has developed 
in this example of near complete DiGeorge syndrome is quite 
distinct from the fetal repertoire and does not appear to be 
clonally restricted in terms of use of germline genes. At most, 
only six genes isolated from the patient with DiGeorge syn- 
drome were derived from the fetal subset (Table 1). 
Overall,  a minimum of 19 different germline genes were 
found to be expressed in these libraries, inconsistent with a 
limited repertoire (14). Furthermore the RACE clones de- 
rived from the same germline parent use multiple, different 
DH and JR segments, and the different junctional N  nucleo- 
tides confirm their uniqueness, arguing strongly against any 
underlying defect in B cell clonal expansion as the basis for 
antibody deficiency. The overlap between germline gene usage 
in the human cord blood library and that observed in this 
patient is probably minimal. 
D# sequences have previously been described in patients 
with primary immunodeficiency as well as in normal indi- 
viduals, and their functional significance in the murine system 
has been defined (26). The apparent increased frequency of 
these transcripts in some primary immunodeficiencies may 
relate to reduced numbers of typical B cell transcripts. A unique 
transcript found in the complete DiGeorge syndrome patient 
appears to represent a recombination event between J, and 
another region possessing a heptamer element. It will be of 
interest to determine whether a similar transcription product 
can be found in other patients with equivalent T  cell de- 
ficiencies. 
The availability of the recently expanded human V. data- 
base and the physical map of the V. locus has greatly facili- 
tated the precise identification of germline genes for our anal- 
ysis. Previously, separation of cDNAs derived from the various 
genes of the GLSJ2/3005/9-III complex was not possible and 
all of these highly related germline genes were termed "fetal" 
However, it recently has been determined that in the 56P1(-) 
haplotype, the predominant fetal gene is V26 (7),  not the 
more closely related (to 56P1) genes 9-III or 3005. Further- 
more, it has been suggested that the recurrence of certain 
sequences in different studies is consistent with the normal 
human V. repertoire being limited to the expression of •25 
germline genes (14). However, that estimate may be some- 
what low due to failure to resolve recently defined, unique 
germline genes. 
It appears that in the DiGeorge syndrome patient a large 
number of genes associated with autoimmune reactivity may 
be expressed; such a circumstance may be avoided (or mini- 
mized) by normal T cell regulation. The significant expres- 
sion of such genes (associated with autoimmune reactivity) 
may be a factor in the secondary pathogenesis of this dis- 
order in which autoreactivity is a frequent, significant  clin- 
ical feature. 
In terms of V. family representation, the composition of 
the conventional library is similar to that accepted for normal 
peripheral blood, i.e., V~III >V,I, IV, and in this sense too, 
a restriction is not apparent in this patient. V~V and V~VI 
genes, which are prominent in the fetal repertoire, were not 
observed in this patient.  Although V.II,  VaV, and V.VI 
genes were not detected in the conventional or RACE libraries, 
these families typically would be expected to account for only 
10-15% of total Ig clones in a normal individual and seem 
to be reduced to undetectable levels in this patient. Screening 
of a large number of recombinants in the RACE library failed 
to reveal members of these families, although they have been 
detected both in RACE libraries of the age-matched control 
and in those of other immunodeficiency patients (our un- 
published results) as well as in the conventional library from 
the normal adult. D. segment usage in this DiGeorge syn- 
drome patient primarily involves DXP and DLR segments 
and normal J. element usage,  whereas the fetal repertoire 
frequently uses DQ52 and Ja  1, 2,  and 3 (5). 
The CDK3 region length in this DiGeorge syndrome pa- 
tient is typical for age-matched normal controls. The rela- 
tively limited occurrence of P nucleotides also argues against 
the use of a fetal repertoire in the complete DiGeorge pa- 
tient. However, the presence of a high proportion of sequences 
identified with autoantibody activity, the Dtt transcripts, and 
the absence of somatic mutation in the cDNAs are consis- 
tent with a fetal or antigenetically primitive repertoire. 
The repertoire observed in the patient with partial DiGeorge 
syndrome, a condition intermediate between normal and com- 
plete DiGeorge syndrome, shares a significant fraction (50- 
64%) of expressed germline genes with that seen in the blood 
of the patient with the complete DiGeorge syndrome. There 
appear to be two classes of sequences in the patient with par- 
tial DiGeorge syndrome, those that are unmutated and a few 
highly mutated transcripts. Perhaps this phenomenon reflects 
a T  cell defect that results in both a reduced incidence of 
somatic mutation and subsequent deficient regulation in se- 
lection of B cell clones. 
Although  the  majority  of  the  patient's  B  cells  were 
CD5 +, we do not consider it to be atypical,  as similar per- 
centages of CD5 + B cells are found in normal infants.  The 
832  Immunoglobulin  V. Repertoire in DiGeorge Syndrome question as to whether B cells are derived from distinct lineages 
remains controversial (27, 28). It is apparent that CDS-  B 
cells can be induced in both human and mouse to express 
CD5. In the mouse, there is a preferential usage of proximal 
V. segments in CD5 + B cells (29, 30). Our data show no 
preferential usage of V. segments and thus are inconsistent 
with preferential usage in human CD5 + cells. 
The unique repertoire observed in the patient with com- 
plete DiGeorge syndrome reflects the influence of abnormal 
thymic differentiation and development of the T cell system 
on B cell ontogenetic development (31). However, the T cell 
effect does not result in a fetal repertoire, but rather is reflected 
in a general failure of B cell diversification as reflected in the 
level of somatic mutation. In the 9,000 informative nucleo- 
tides identified in the present study, only five differ from 
data on existing germline sequences derived from unrelated 
individuals, suggesting not only a marked reduction in so- 
matic mutation but a very low level of V, polymorphism 
in humans. The number of differences encountered from germ- 
line  sequences is  equivalent  to  the rate of error in  PCR 
amplification, which we estimate as ,~1:1,700  nucleotides. 
Evidence for limited occurrence of somatic mutation in this 
patient is based on comparison both to adult and age-matched 
controls,  as well as to analysis  of cord blood data (6). 
Somatic mutation is already well established by the time 
of birth in humans and continues to represent a source of 
Ig diversification within the peripheral B cells throughout 
adult life (3). Absence of somatic mutation in the complete 
DiGeorge syndrome patient accounts for the inability of such 
patients to mount an effective immune response to microbial 
pathogens.  Thus,  despite low to near normal levels of Ig, 
the quality of antibody produced as judged by both specificity 
and affinity must be markedly reduced. Infusion of normal 
Ig (intravenous gamma globulin) is a standard course of therapy 
in patients with DiGeorge syndrome. 
The absence of somatic mutation may relate to T cell de- 
pendence of the ontogeny of normal B cell functional matu- 
ration. Mouse B lymphocytes acquire the capacity to give 
a normal adult-like heterologous response between 7 and 10 d 
of age (32, 33), and this functional maturation is indepen- 
dent of antigenic drive since it is observed in germ-free mice 
(34).  In a model using irradiated mice, reconstituted with 
adult thymocytes and B cells from fetal liver and adult spleen, 
the maturation of B cells to produce antibodies with heter- 
ogenous affinities is shown to depend on cells derived from 
thymus. Based on the findings reported here, diverse usage 
of V, genes in B cells is independent of T-B interaction(s). 
However, somatic maturation is dependent on T  cells that 
are absent (or greatly reduced) in complete DiGeorge syn- 
drome patients and in neonatal mice, but present to some 
degree in patients with partial DiGeorge syndrome, devel- 
oped in human neonates, and developed to some degree in 
human fetuses, which have normal thymus functions. Thus, 
the generation of a B cell repertoire can be considered a two- 
step process, i.e., diversification ofa V repertoire and somatic 
mutation. In patients with complete DiGeorge syndrome who 
have profound failure of thymus development, the V reper- 
toire diversified but somatic mutation is compromised. This 
two-stage hypothesis may explain the functional antibody 
deficiency noted in patients with other immunodeflciency  syn- 
dromes and significant levels of circulating Ig. 
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